Based on 5 reviews
EyeFollow is a remote ophthalmology follow-up platform that connects patients with their ophthalmologist between in-person visits. The service is currently in private beta, with new patient accounts created through invitations from their ophthalmologist and clinician accounts provisioned by the company's founder. EyeFollow states that it is a follow-up tool and does not replace medical examinations or emergency care.
Patients can use the EyeFollow app to complete vision tests, use an Amsler grid, submit photos, report symptoms, and track medication. The process requires patients to receive an invitation directly from their doctor, as self sign-up is disabled for new accounts. Clinician accounts are provisioned by the EyeFollow founder.
Some reviewers praise the ability to complete vision tests and use an Amsler grid remotely. Users appreciate the convenience of submitting photos and reporting symptoms without needing an in-person appointment. The platform helps track medication adherence between visits.
The official website of EyeFollow is eye-follow.com.
On Trustburn, EyeFollow has a rating of 4.2 out of 5 based on 5 reviews.
AI-generated from reviews on this page. Verify anything important with the company directly.
EyeFollow provides a clear pathway for remote ophthalmology follow-ups. The requirement for ophthalmologist invitation ensures that patients are already under professional care. This structure supports a focused and secure digital health experience.
The remote follow-up concept is sound, but pricing details are not explicitly stated. Does the invitation imply a free service, or are there hidden fees? It is a positive step for accessibility.
From the information available, EyeFollow positions itself as a remote ophthalmology follow-up tool rather than a replacement for medical examinations or emergency care. This distinction is crucial for setting accurate expectations. The private beta status and invitation-only access suggest a controlled environment where the team is likely refining features based on direct feedback from ophthalmologists. For someone considering this company, the focus on clinician-driven access points to a service that prioritizes professional oversight over broad commercial scaling at this stage.
The EyeFollow platform appears to be a legitimate remote ophthalmology follow-up tool, yet prospective users should verify the access model before committing time. Since it is currently in a private beta phase, self-sign-up is disabled, meaning patients must be invited by their ophthalmologist. This gatekeeping mechanism suggests that availability is not guaranteed for everyone. Clinician accounts are provisioned directly by the founder, which implies a high-touch onboarding process. Before assuming this service fits your care routine, it is prudent to confirm whether your specific ophthalmologist participates in this beta program and how their invitation system operates.
EyeFollow offers a streamlined remote ophthalmology follow-up experience. Being invitation-only ensures a focused patient pool. It serves as a convenient alternative for routine check-ins without replacing a full medical examination. The private beta status keeps the service specialized and attentive to user needs.
No news yet. This is where the business shares its own updates and press.
No photos yet. Photos shared by reviewers will show up here.
EyeFollow is a remote ophthalmology follow-up platform that connects patients with their ophthalmologist between in-person visits. Through its app, patients can complete vision tests, use an Amsler grid, submit photos, report symptoms, and track medication. The service is currently in private beta, with new patient accounts created through invitations from their ophthalmologist and clinician accounts provisioned by the company's founder. EyeFollow states that it is a follow-up tool and does not replace medical examinations or emergency care.